373 related articles for article (PubMed ID: 33845381)
1. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
Bajaj S; Kumar MS; Tinwala H; Yc M
Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
Bajaj S; Roy PP; Singh J
Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, SAR elucidations and molecular docking study of newly designed isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase.
Javid MT; Rahim F; Taha M; Nawaz M; Wadood A; Ali M; Mosaddik A; Shah SAA; Farooq RK
Bioorg Chem; 2018 Sep; 79():323-333. PubMed ID: 29803079
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, thymidine phosphorylase inhibition and molecular modeling studies of 1,3,4-oxadiazole-2-thione derivatives.
Shahzad SA; Yar M; Bajda M; Shahzadi L; Khan ZA; Naqvi SA; Mutahir S; Mahmood N; Khan KM
Bioorg Chem; 2015 Jun; 60():37-41. PubMed ID: 25920005
[TBL] [Abstract][Full Text] [Related]
7. Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase.
Taha M; Rashid U; Imran S; Ali M
Bioorg Med Chem; 2018 Jul; 26(12):3654-3663. PubMed ID: 29853339
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
Ananth AH; Manikandan N; Rajan RK; Elancheran R; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Kabilan S
Chem Biodivers; 2020 Feb; 17(2):e1900659. PubMed ID: 31995280
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.
Lakshmithendral K; Saravanan K; Elancheran R; Archana K; Manikandan N; Arjun HA; Ramanathan M; Lokanath NK; Kabilan S
Eur J Med Chem; 2019 Apr; 168():1-10. PubMed ID: 30798049
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.
Shahzad SA; Sarfraz A; Yar M; Khan ZA; Naqvi SAR; Naz S; Khan NA; Farooq U; Batool R; Ali M
Bioorg Chem; 2020 Jul; 100():103876. PubMed ID: 32388426
[TBL] [Abstract][Full Text] [Related]
12. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
Bera H; Lee MH; Sun L; Dolzhenko AV; Chui WK
Bioorg Chem; 2013 Oct; 50():34-40. PubMed ID: 23968897
[TBL] [Abstract][Full Text] [Related]
14. In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.
Taha M; Ismail NH; Imran S; Rahim F; Wadood A; Al Muqarrabun LM; Khan KM; Ghufran M; Ali M
Bioorg Chem; 2016 Oct; 68():80-9. PubMed ID: 27474803
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines.
Iftikhar F; Yaqoob F; Tabassum N; Jan MS; Sadiq A; Tahir S; Batool T; Niaz B; Ansari FL; Choudhary MI; Rashid U
Bioorg Chem; 2018 Oct; 80():99-111. PubMed ID: 29894893
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, thymidine phosphorylase, angiogenic inhibition and molecular docking study of isoquinoline derivatives.
Zaman K; Rahim F; Taha M; Wadood A; Adnan Ali Shah S; Gollapalli M; Ullah F; Ahmed A
Bioorg Chem; 2019 Aug; 89():102999. PubMed ID: 31151055
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist.
Andavar S; Vaithilingam M; Selvaraj D; Kumaran AA; Devanathan K
Anticancer Agents Med Chem; 2020; 20(1):84-93. PubMed ID: 31755396
[TBL] [Abstract][Full Text] [Related]
19. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
